Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1857) 1857
Publication (103) 103
Book Review (40) 40
Book Chapter (35) 35
Conference Proceeding (4) 4
Magazine Article (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1489) 1489
index medicus (1302) 1302
drug-eluting stents (1250) 1250
cardiac & cardiovascular systems (1026) 1026
male (921) 921
female (903) 903
treatment outcome (763) 763
aged (737) 737
middle aged (719) 719
stents (667) 667
percutaneous coronary intervention (521) 521
stent (513) 513
follow-up studies (447) 447
time factors (439) 439
thrombosis (435) 435
risk factors (394) 394
cardiovascular (385) 385
abridged index medicus (376) 376
implantation (368) 368
angioplasty (358) 358
drug-eluting stent (350) 350
restenosis (295) 295
retrospective studies (293) 293
mortality (284) 284
coronary artery disease - therapy (278) 278
cardiology (275) 275
heart attacks (275) 275
care and treatment (269) 269
coronary artery disease - surgery (253) 253
intervention (253) 253
transluminal angioplasty (246) 246
bare-metal stents (245) 245
registries (245) 245
outcomes (244) 244
prospective studies (244) 244
coronary angiography (240) 240
drug-eluting stents - trends (237) 237
coronary heart disease (235) 235
prosthesis design (224) 224
drug-eluting stents - adverse effects (218) 218
revascularization (214) 214
coronary vessels (209) 209
survival rate - trends (201) 201
coronary artery disease (198) 198
analysis (191) 191
sirolimus - administration & dosage (188) 188
percutaneous coronary intervention - adverse effects (184) 184
cardiovascular disease (183) 183
percutaneous coronary intervention - methods (183) 183
follow-up (182) 182
surgery (181) 181
usage (176) 176
trial (175) 175
coronary artery disease - mortality (174) 174
cardiac patients (171) 171
artery-disease (170) 170
incidence (167) 167
aged, 80 and over (159) 159
metaanalysis (158) 158
coronary restenosis - prevention & control (154) 154
myocardial infarction (154) 154
patient outcomes (153) 153
studies (152) 152
health aspects (143) 143
coronary artery bypass (142) 142
disease (138) 138
angioplasty, balloon, coronary - instrumentation (137) 137
risk assessment (137) 137
angioplasty, balloon, coronary - adverse effects (135) 135
percutaneous coronary intervention - instrumentation (135) 135
peripheral vascular disease (131) 131
patients (130) 130
percutaneous coronary intervention - trends (129) 129
acute myocardial-infarction (126) 126
angioplasty, balloon, coronary - methods (126) 126
kaplan-meier estimate (126) 126
sirolimus - analogs & derivatives (126) 126
implants (125) 125
myocardial-infarction (124) 124
cardiovascular diseases (122) 122
coronary-artery-disease (122) 122
diabetes (122) 122
paclitaxel (122) 122
clinical-outcomes (121) 121
animals (119) 119
research (117) 117
paclitaxel - administration & dosage (116) 116
risk (116) 116
coronary artery disease - diagnostic imaging (112) 112
surgical implants (112) 112
prognosis (109) 109
angioplasty, balloon, coronary (108) 108
clinical outcomes (107) 107
coronary artery disease - diagnosis (105) 105
everolimus (105) 105
myocardial infarction - etiology (105) 105
randomized-trial (105) 105
myocardial infarction - therapy (104) 104
percutaneous coronary intervention - mortality (103) 103
sirolimus (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1854) 1854
German (11) 11
Spanish (8) 8
French (6) 6
Japanese (5) 5
Russian (5) 5
Chinese (4) 4
Polish (3) 3
Italian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Coronary stents: Looking forward
by Garg, Scot and Serruys, Patrick W
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2010, Volume 56, Issue 10, pp. S43 - S78
Despite all the benefits of drug-eluting stents (DES), concerns have been raised over their long-term safety, with particular reference to stent thrombosis. In... 
biodegradable polymer stents | drug-eluting stents | biodegradable stents | coronary stents | polymer-free drug-eluting stents | CARDIAC & CARDIOVASCULAR SYSTEMS | OXIDE-COATED STENTS | OPTICAL COHERENCE TOMOGRAPHY | BARE-METAL STENTS | LONG-TERM OUTCOMES | 2-YEAR FOLLOW-UP | DIFFERENT COATING STRATEGIES | TAXUS LIBERTE STENT | MUSCLE-CELL-PROLIFERATION | NANOTHIN POLYZENE-F | Coronary Vessels - pathology | Drug-Eluting Stents - trends | Angioplasty, Balloon, Coronary - instrumentation | Absorbable Implants - standards | Coronary Vessels - physiology | Humans | Equipment Design - standards | Coronary Restenosis - prevention & control | Angioplasty, Balloon, Coronary - trends | Absorbable Implants - trends | Animals | Clinical Trials as Topic - trends | Drug-Eluting Stents - standards | Equipment Design - trends | Coronary Restenosis - etiology | Biodegradation | Studies | Technological change | Magnesium | Polymers | Stents | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Coronary stents: Current status
by Garg, Scot and Serruys, Patrick W
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2010, Volume 56, Issue 10, pp. S1 - S42
Coronary artery stents revolutionized the practice of interventional cardiology after they were first introduced in the mid-1980s. Since then, there have been... 
clopidogrel | cost-effectiveness | restenosis | drug-eluting stents | sirolimus-eluting stents | stent fracture | myocardial infarction | bare-metal stents | paclitaxel-eluting stents | left main disease | saphenous vein grafts | stent thrombosis | zotarolimus-eluting stents | everolimus-eluting stents | diabetes | CARDIAC & CARDIOVASCULAR SYSTEMS | SIROLIMUS-ELUTING-STENT | RANDOMIZED CONTROLLED-TRIAL | ACUTE MYOCARDIAL-INFARCTION | INTRAVASCULAR ULTRASOUND PREDICTORS | SAPHENOUS-VEIN GRAFTS | OPTICAL COHERENCE TOMOGRAPHY | CLINICAL FOLLOW-UP | LONG-TERM SAFETY | CHRONIC TOTAL OCCLUSION | Coronary Vessels - pathology | Drug-Eluting Stents - trends | Angioplasty, Balloon, Coronary - instrumentation | Coronary Vessels - physiology | United States | Humans | Coronary Restenosis - prevention & control | Device Approval | Drug-Eluting Stents - adverse effects | Angioplasty, Balloon, Coronary - trends | Animals | Drug-Eluting Stents - standards | Stents - trends | Clinical Trials as Topic - methods | Angioplasty, Balloon, Coronary - standards | Stents - adverse effects | Stents - standards | Coronary Restenosis - etiology | Heart attacks | Angioplasty | Coronary vessels | Cardiovascular disease | Smooth muscle | Drug therapy | Stents | Thrombosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis
by Palmerini, Tullio and Benedetto, Umberto and Biondi-Zoccai, Giuseppe and Della Riva, Diego and Bacchi-Reggiani, Letizia and Smits, Pieter C and Vlachojannis, Georgios J and Jensen, Lisette Okkels and Christiansen, Evald H and Berencsi, Klára and Valgimigli, Marco and Orlandi, Carlotta and Petrou, Mario and Rapezzi, Claudio and Stone, Gregg W
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2015, Volume 65, Issue 23, pp. 2496 - 2507
Background Previous meta-analyses have investigated the relative safety and efficacy profiles of different types of drug-eluting stents (DES) and bare-metal... 
meta-analysis | bare-metal stent(s) | stent thrombosis | drug-eluting stent(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | NON-INFERIORITY TRIAL | FOLLOW-UP | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | ENDEAVOR IV TRIAL | CORONARY-ARTERY-DISEASE | ELEVATION MYOCARDIAL-INFARCTION | BIODEGRADABLE-POLYMER | DURABLE-POLYMER | CLINICAL-OUTCOMES | Myocardial Infarction - diagnosis | Percutaneous Coronary Intervention - trends | Drug-Eluting Stents - trends | Myocardial Infarction - epidemiology | Follow-Up Studies | Humans | Thrombosis - epidemiology | Treatment Outcome | Metals - adverse effects | Drug-Eluting Stents - adverse effects | Percutaneous Coronary Intervention - instrumentation | Time Factors | Stents - trends | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Randomized Controlled Trials as Topic - trends | Thrombosis - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial
by Gao, Runlin and Gao, Runlin and Yang, Yuejin and Yang, Yuejin and Han, Yaling and Han, Yaling and Huo, Yong and Huo, Yong and Chen, Jiyan and Chen, Jiyan and Yu, Bo and Yu, Bo and Su, Xi and Su, Xi and Li, Lang and Li, Lang and Kuo, Hai-Chien and Kuo, Hai-Chien and Ying, Shih-Wa and Ying, Shih-Wa and Cheong, Wai-Fung and Cheong, Wai-Fung and Zhang, Yunlong and Zhang, Yunlong and Su, Xiaolu and Su, Xiaolu and Xu, Bo and Xu, Bo and Popma, Jeffery J and Popma, Jeffery J and Stone, Gregg W and Stone, Gregg W and ABSORB China Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 2015, Volume 66, Issue 21, pp. 2298 - 2309
Background The everolimus-eluting bioresorbable vascular scaffold (BVS) is designed to achieve results comparable to metallic drug-eluting stents at 1 year,... 
stent | everolimus | bioresorbable vascular scaffold | randomized controlled trial | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | RANDOMIZED-TRIALS | END-POINTS | DEVICES | OUTCOMES | DRUG-ELUTING STENTS | Coronary Artery Disease - surgery | Drug-Eluting Stents - trends | Prospective Studies | Absorbable Implants - standards | Follow-Up Studies | Metals - standards | Humans | Middle Aged | Male | Treatment Outcome | China - epidemiology | Radiography | Coronary Artery Disease - diagnostic imaging | Absorbable Implants - trends | Drug-Eluting Stents - standards | Female | Aged | Coronary Artery Disease - epidemiology | Stents - trends | Tissue Scaffolds - standards | Stents - standards | Tissue Scaffolds - trends | Care and treatment | Coronary heart disease | Cardiac patients | Stent (Surgery)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Optical coherence tomography findings in patients with coronary stent thrombosis: A report of the PRESTIGE consortium (prevention of late stent thrombosis by an interdisciplinary global european effort)
by Adriaenssens, Tom and Joner, Michael and Godschalk, Thea C and Malik, Nikesh and Alfonso, Fernando and Xhepa, Erion and De Cock, Dries and Komukai, Kenichi and Tada, Tomohisa and Cuesta, Javier and Sirbu, Vasile and Feldman, Laurent J and Neumann, Franz-Josef and Goodall, Alison H and Heestermans, Ton and Buysschaert, Ian and Hlinomaz, Ota and Belmans, Ann and Desmet, Walter and Ten Berg, Jurrien M and Gershlick, Anthony H and Massberg, Steffen and Kastrati, Adnan and Guagliumi, Giulio and Byrne, Robert A and PREvention late Stent Thrombosis I and Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE) Investigators
Circulation, ISSN 0009-7322, 09/2017, Volume 136, Issue 11, pp. 1007 - 1021
BACKGROUND: Stent thrombosis (ST) is a serious complication following coronary stenting. Intravascular optical coherence tomography (OCT) may provide insights... 
Uncovered struts | Malapposition | Stents | Thrombosis | Tomography, optical coherence | Atherosclerosis | atherosclerosis | BASE-LINE | CARDIAC & CARDIOVASCULAR SYSTEMS | stents | BARE-METAL STENTS | ACQUISITION | MECHANISMS | tomography, optical coherence | uncovered struts | INTERVENTIONS | thrombosis | NEOATHEROSCLEROSIS | CLINICAL PRESENTATION | RESTENOSIS | PERIPHERAL VASCULAR DISEASE | malapposition | ASSOCIATION | DRUG-ELUTING STENTS | Percutaneous Coronary Intervention - trends | Drug-Eluting Stents - trends | Prospective Studies | Coronary Thrombosis - epidemiology | Humans | Europe - epidemiology | Male | Tomography, Optical Coherence - methods | Drug-Eluting Stents - adverse effects | Coronary Thrombosis - diagnostic imaging | Coronary Thrombosis - prevention & control | Female | Registries | Aged | Research Report - trends | Tomography, Optical Coherence - trends | Percutaneous Coronary Intervention - adverse effects | 10153 | Original s | 10149
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Stent thrombosis and restenosis: What have we learned and where are we going? the Andreas Grüntzig Lecture ESC 2014
by Byrne, Robert A and Joner, Michael and Kastrati, Adnan
European Heart Journal, ISSN 0195-668X, 12/2015, Volume 36, Issue 47, pp. 3320 - 3331
Modern-day stenting procedures leverage advances in pharmacotherapy and device innovation. Patients treated with contemporary antiplatelet agents,... 
In-stent restenosis | Neoatherosclerosis | Stent thrombosis | Bioresorbable stents | Coronary artery disease | Drug-eluting stents | CARDIAC & CARDIOVASCULAR SYSTEMS | DUAL-ANTIPLATELET THERAPY | MYOCARDIAL-INFARCTION | ANGIOGRAPHIC FOLLOW-UP | DRUG-ELUTING-STENTS | CLOPIDOGREL THERAPY | PERCUTANEOUS CORONARY INTERVENTION | ROUTINE CLINICAL-PRACTICE | DOUBLE-BLIND | BARE-METAL STENT | PLATELET REACTIVITY | Percutaneous Coronary Intervention - trends | Drug-Eluting Stents - trends | Humans | Middle Aged | Risk Factors | Graft Occlusion, Vascular - prevention & control | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Absorbable Implants | Drug-Eluting Stents - adverse effects | Graft Occlusion, Vascular - etiology | Prosthesis Failure | Coronary Thrombosis - prevention & control | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Coronary Restenosis - etiology | Reviews
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Second-Generation Drug-Eluting Stent Implantation Followed by 6-Versus 12-Month Dual Antiplatelet Therapy The SECURITY Randomized Clinical Trial
by Colombo, A and Chieffo, A and Frasheri, A and Garbo, R and Masotti-Centol, M and Salvatella, N and Dominguez, JFO and Steffanon, L and Tarantini, G and Presbitero, P and Menozzi, A and Pucci, E and Mauri, J and Cesana, BM and Giustino, G and Sardella, G
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 11/2014, Volume 64, Issue 20, pp. 2086 - 2097
BACKGROUND The optimal duration of dual antiplatelet therapy (DAPT) following second-generation drug-eluting stent (DES) implantation is still debated.... 
coronary artery disease | MULTICENTER | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | stents | DISCONTINUATION | DEFINITIONS | percutaneous coronary intervention | thrombosis | platelet aggregation inhibitors | PREDICTORS | prospective studies | OUTCOMES | DURATION | ARTERY-DISEASE | Percutaneous Coronary Intervention - trends | Drug-Eluting Stents - trends | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Coronary Disease - diagnosis | Time Factors | Internationality | Platelet Aggregation Inhibitors - administration & dosage | Coronary Disease - drug therapy | Female | Aged | Coronary Disease - surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: A report from SCAAR
by Sarno, Giovanna and Lagerqvist, Bo and Nilsson, Johan and Frobert, Ole and Hambraeus, Kristina and Varenhorst, Christoph and Jensen, Ulf J and Tödt, Tim and Götberg, Matthias and James, Stefan K and Kardiologi and Cardiology and Lund University and Lunds universitet
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2014, Volume 64, Issue 1, pp. 16 - 24
BACKGROUND: Some concerns still have not been resolved about the long-term safety of drug-eluting stents (DES) in patients with acute STEMI. OBJECTIVES: The... 
percutaneous coronary intervention | ST-segment elevation myocardial infarction | drug-eluting stent(s) | Coronary Thrombosis - mortality | Myocardial Infarction - surgery | Percutaneous Coronary Intervention - trends | Drug-Eluting Stents - trends | Myocardial Infarction - mortality | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Mortality - trends | Myocardial Infarction - diagnostic imaging | Sweden - epidemiology | Drug-Eluting Stents - adverse effects | Coronary Thrombosis - diagnostic imaging | Angioplasty, Balloon, Coronary - trends | Female | Registries | Aged | Coronary Thrombosis - etiology | Coronary Angiography - trends | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: A Meta-Analysis of Randomized Controlled Trials
by Montone, Rocco A and Niccoli, Giampaolo and De Marco, Federico and Minelli, Silvia and D’Ascenzo, Fabrizio and Testa, Luca and Bedogni, Francesco and Crea, Filippo
Circulation, ISSN 0009-7322, 05/2017, Volume 135, Issue 22, pp. 2145 - 2154
BACKGROUND:Bioresorbable coronary stents have been introduced into clinical practice to improve the outcomes of patients treated with percutaneous coronary... 
treatment outcome | stents | thrombosis | SYSTEMATIC REVIEWS | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | SAFETY | LONG-TERM OUTCOMES | FOLLOW-UP | NETWORK METAANALYSIS | ABSORB JAPAN | PERIPHERAL VASCULAR DISEASE | CORONARY-ARTERY-DISEASE | INSIGHTS | Myocardial Infarction - diagnosis | Absorbable Implants - adverse effects | Drug-Eluting Stents - trends | Tissue Scaffolds - adverse effects | Randomized Controlled Trials as Topic - methods | Humans | Myocardial Revascularization - trends | Everolimus - administration & dosage | Metals - adverse effects | Drug-Eluting Stents - adverse effects | Absorbable Implants - trends | Time Factors | Thrombosis - etiology | Everolimus - adverse effects | Stents - trends | Stents - adverse effects | Myocardial Infarction - etiology | Tissue Scaffolds - trends | Thrombosis - diagnosis | Treatment outcome | Usage | Care and treatment | Safety and security measures | Analysis | Drug-eluting stents | Thrombosis | Blood clot
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Coronary stents: Historical development, current status and future directions
by Iqbal, Javaid and Gunn, Julian and Serruys, Patrick W
British Medical Bulletin, ISSN 0007-1420, 06/2013, Volume 106, Issue 1, pp. 193 - 211
Coronary angioplasty with stenting has revolutionized the treatment of coronary artery disease. This article describes the history of coronary angioplasty and... 
drug-eluting stents | bare metal stents | bioresorbable vascular scaffold | stents | angioplasty | BARE-METAL STENTS | PERCUTANEOUS CORONARY | NON-INFERIORITY TRIAL | FOLLOW-UP | ANTIPLATELET THERAPY | MEDICINE, GENERAL & INTERNAL | BALLOON ANGIOPLASTY | INTRAVASCULAR ULTRASOUND | ARTERY-DISEASE | Angioplasty, Balloon, Coronary - trends | Drug-Eluting Stents | Coronary Artery Disease - therapy | Humans | Stents - trends | Platelet Aggregation Inhibitors - therapeutic use | Equipment Design | Absorbable Implants | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text New Drug-Eluting Stents: An Overview on Biodegradable and Polymer-Free Next-Generation Stent Systems
by Abizaid, Alexandre and Costa, J Ribamar
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 08/2010, Volume 3, Issue 4, pp. 384 - 393
TRIAL | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | IMPLANTATION | NOVO CORONARY LESIONS | APPOSITION | MODEL | Constriction, Pathologic - prevention & control | Drug-Eluting Stents - trends | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Constriction, Pathologic - etiology | Angioplasty | Lactic Acid | Humans | Metals | Endothelium, Vascular - drug effects | Clinical Trials as Topic | Coated Materials, Biocompatible | Drug-Eluting Stents - adverse effects | Animals | Polyesters | Endothelium, Vascular - pathology | Polymers | Postoperative Complications
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry)
by Rymer, Jennifer A and Harrison, Robert W and Dai, David and Roe, Matthew T and Messenger, John C and Anderson, H. Vernon and Peterson, Eric D and Wang, Tracy Y
The American Journal of Cardiology, ISSN 0002-9149, 10/2016, Volume 118, Issue 7, pp. 959 - 966
In 2006, the United States (US) Food and Drug Administration published advisory highlighting concerns for late drug-eluting stent thrombosis; its impact on US... 
MORTALITY | LINKING | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | OFF-LABEL USE | AMERICAN-COLLEGE | CARDIAC-CATHETERIZATION | OUTCOMES | CARDIOVASCULAR DATA REGISTRY | DRUG-ELUTING STENTS | MEDICARE PATIENTS | Percutaneous Coronary Intervention - trends | United States - epidemiology | Drug-Eluting Stents | Myocardial Infarction - epidemiology | Medicare | Humans | Metals | Mortality | Postoperative Hemorrhage - epidemiology | Proportional Hazards Models | Male | Thrombosis - epidemiology | Postoperative Complications - epidemiology | Cause of Death | Myocardial Revascularization - utilization | Percutaneous Coronary Intervention - instrumentation | Aged, 80 and over | Female | Registries | Aged | Stents - trends | Graft Occlusion, Vascular - epidemiology | United States Food and Drug Administration | Transluminal angioplasty | Medical colleges | Stent (Surgery) | Confidence intervals | Variables | Heart attacks | Heart surgery | Coronary vessels | Trends | Health risk assessment | Stents | Thrombosis | Patients | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Bioresorbable scaffold: The advent of a new era in percutaneous coronary and peripheral revascularization?
by Onuma, Yosinobu and Serruys, Patrick W
Circulation, ISSN 0009-7322, 02/2011, Volume 123, Issue 7, pp. 779 - 797
coronary artery disease | coronary stent | bioresorbable scaffold | biodegradable polymers | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL STENTS | FOLLOW-UP | POLY-L-LACTIDE | ROUTINE CLINICAL-PRACTICE | ALIPHATIC POLYESTERS | BALLOON ANGIOPLASTY | PERIPHERAL VASCULAR DISEASE | INTRAVASCULAR ULTRASOUND | ARTERY STENOSIS | NEOINTIMAL PROLIFERATION | DRUG-ELUTING STENTS | Angioplasty, Balloon, Coronary - trends | Angioplasty, Balloon, Coronary - instrumentation | Animals | Coronary Artery Disease - therapy | Humans | Stents - trends | Polymers | Tissue Scaffolds - trends | Cardiology - trends | Complications and side effects | Care and treatment | Usage | Forecasts and trends | Coronary heart disease | Biopolymers | Endovascular stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: The PLATINUM (a prospective, randomized, multicenter trial to assess an everolimus-eluting coronary stent system [PROMUS element] for the treatment of up to two de novo coronary artery lesions) trial
by Stone, Gregg W and Teirstein, Paul S and Meredith, Ian T and Farah, Bruno and Dubois, Christophe L and Feldman, Robert L and Dens, Joseph and Hagiwara, Nobuhisa and Allocco, Dominic J and Dawkins, Keith D and PLATINUM Trial Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2011, Volume 57, Issue 16, pp. 1700 - 1708
Objectives: We sought to evaluate the clinical outcomes with a novel platinum chromium everolimus-eluting stent (PtCr-EES) compared with a predicate cobalt... 
coronary artery disease | restenosis | angioplasty | Single-Blind Method | Coronary Artery Disease - surgery | Drug-Eluting Stents - trends | Sirolimus - analogs & derivatives | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Coronary Artery Disease - drug therapy | Sirolimus - administration & dosage | Coronary Artery Disease - physiopathology | Drug-Eluting Stents - standards | Female | Aged | Everolimus | Heart attacks | Angina pectoris | Angioplasty | Stents | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography
by Taniwaki, Masanori and Radu, Maria D and Zaugg, Serge and Amabile, Nicolas and Garcia-Garcia, Hector M and Yamaji, Kyohei and Jørgensen, Erik and Kelbæk, Henning and Pilgrim, Thomas and Caussin, Christophe and Zanchin, Thomas and Veugeois, Aurelie and Abildgaard, Ulrik and Jüni, Peter and Cook, Stephane and Koskinas, Konstantinos C and Windecker, Stephan and Räber, Lorenz
Circulation, ISSN 0009-7322, 02/2016, Volume 133, Issue 7, pp. 650 - 660
BACKGROUND—The pathomechanisms underlying very late stent thrombosis (VLST) after implantation of drug-eluting stents (DES) are incompletely understood. Using... 
drug-eluting stents | thrombosis | tomography, optical coherence | stents | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOINTIMAL COVERAGE | BARE-METAL | PATHOLOGY | CORONARY-ARTERY | INTRAVASCULAR ULTRASOUND FINDINGS | NEOATHEROSCLEROSIS | IMPLANTATION | PERIPHERAL VASCULAR DISEASE | Coronary Vessels - pathology | Drug-Eluting Stents - trends | Cross-Sectional Studies | Humans | Middle Aged | Male | Tomography, Optical Coherence - methods | Drug-Eluting Stents - adverse effects | Prosthesis Failure | Time Factors | Drug-Eluting Stents - standards | Thrombosis - etiology | Coronary Vessels - surgery | Female | Aged | Thrombosis - diagnosis | Usage | Analysis | Coherence (Optics) | Drug-eluting stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Predictors of Reocclusion After Successful Drug-Eluting Stent–Supported Percutaneous Coronary Intervention of Chronic Total Occlusion
by Valenti, Renato, MD and Vergara, Ruben, MD and Migliorini, Angela, MD and Parodi, Guido, MD and Carrabba, Nazario, MD and Cerisano, Giampaolo, MD and Dovellini, Emilio Vincenzo, MD and Antoniucci, David, MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 5, pp. 545 - 550
Objectives This study sought to assess the incidence of reocclusion and identification of predictors of angiographic failure after successful chronic total... 
Cardiovascular | Internal Medicine | chronic coronary occlusion | stent reocclusion | SURVIVAL | TRIAL | REENTRY | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | SUBINTIMAL TRACKING | EXPERIENCE | OUTCOMES | Percutaneous Coronary Intervention - trends | Predictive Value of Tests | Drug-Eluting Stents - trends | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Coronary Occlusion - diagnosis | Coronary Occlusion - epidemiology | Female | Registries | Aged | Chronic Disease | Transluminal angioplasty | Cardiology | Stent (Surgery) | Heart attacks | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights